Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa and Droxidopa/Carbidopa in Fibromyalgia
NCT01323374Phase 2Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Jan 2009
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of droxidopa in fibromyalgia (FM), sponsored by Chelsea Therapeutics International, Ltd.. Started Jan 2009; status: completed.
02
Drugs
droxidopa
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01323374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323374.